Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bress

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Genetic and Social Determinants of Renin-Angiotensin-Aldosterone System Inhibitor-Induced Angioedema: A Precision Medicine Health Equity StudyNanase Toda, Tanushree Haldar, Craig C Teerlink, et al.
Plos One|August 13, 2013
Association of aldosterone synthase polymorphism (CYP11B2 -344T>C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failureAdam Bress, Jin Han, Shitalben R Patel, et al.
Journal of General Internal Medicine|August 9, 2022
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention TrialDae Hyun Kim, Curtis Tatsuoka, Zhengyi Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Clinical validation of a statin-benefit polygenic score using real-world cohorts of primary prevention participantsTanushree Haldar, Kyung Min Lee, Craig C Teerlink, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver DiseaseHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
American Journal of Human Genetics|August 8, 2025
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunctionHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Genetic and Social Determinants of Renin-Angiotensin-Aldosterone System Inhibitor-Induced Angioedema: A Precision Medicine Health Equity StudyNanase Toda, Tanushree Haldar, Craig C Teerlink, et al.
Plos One|August 13, 2013
Association of aldosterone synthase polymorphism (CYP11B2 -344T>C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failureAdam Bress, Jin Han, Shitalben R Patel, et al.
Journal of General Internal Medicine|August 9, 2022
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention TrialDae Hyun Kim, Curtis Tatsuoka, Zhengyi Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Clinical validation of a statin-benefit polygenic score using real-world cohorts of primary prevention participantsTanushree Haldar, Kyung Min Lee, Craig C Teerlink, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver DiseaseHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
American Journal of Human Genetics|August 8, 2025
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunctionHannah M Seagle, Alexis T Akerele, Joseph A DeCorte, et al.
Pageof 3